RSS   Newsletter   Contact   Advertise with us

Insmed adds David R. Brennan to its board

Staff writer | Monmouth Junction, NJ, USA | May 30, 2014
David R. BrennanMay 30, 2014, Monmouth Junction, NJ, USA - Insmed Incorporated, a biopharmaceutical company, announced the appointment of David R. Brennan to its board of directors.
Mr. Brennan has more than 37 years of experience in the pharmaceutical industry. From 2006 to 2012 Mr. Brennan served as Chief Executive Officer of AstraZeneca, a global pharmaceutical company. He started his career in sales at Merck and Co. and quickly ascended into management roles at Merck.

Mr. Brennan continued to take on increasing managerial and executive roles at Astra Merck and then Astra Pharmaceuticals. He became an executive at AstraZeneca when Astra and Zeneca merged in 1999.

He has been an executive member of several leading industry associations, including former Chairman of Pharmaceutical Research and Manufacturers of America (PhRMA), executive board member of the European Federation of Pharmaceuticals Industries and Associations (EFPIA) and former President of the International Federation of Pharmaceuticals Manufacturers and Associations (IFPMA).

Mr. Brennan received a bachelor's degree in business administration from Gettysburg College.